Evaluation of a cholinomimetic drug, 9-amino-2,3,5,6,7,8-hexahydro-1h-cyclopenta [b] quinoline (NIK-247), as an enhancer of endogenous efflux of acetylcholine from brain slices

This publication has 28 references indexed in Scilit:

• Modulation of γ‐Aminobutyric Acid Release in Cerebral Cortex by Fluoride, Phorbol Ester, and Phosphodiesterase Inhibitors: Differential Sensitivity of Acetylcholine Release to Fluoride and K⁺ Channel Blockers
  Journal of Neurochemistry, 1990
• Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
• Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
  New England Journal of Medicine, 1986
• Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
• Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
  Science, 1983
• The organization and some projections of cholinergic neurons of the mammalian forebrain
  Brain Research Reviews, 1982
• The Cholinergic Hypothesis of Geriatric Memory Dysfunction
  Science, 1982
• Radioimmunoassay for acetylcholine in the rat brain
  Journal of Pharmacological Methods, 1980
• SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
  Published by Elsevier ,1976
• THE DETERMINATION OF PICOMOLE AMOUNTS OF ACETYLCHOLINE IN MAMMALIAN BRAIN
  Journal of Neurochemistry, 1973